SCHEMBL9965929

SCHEMBL9965929

COc1ccc2c(c1)C(=O)CC1(CCCN(C)C1)O2

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC3 O15379 6/20 0.58
HDAC4 P56524 6/20 0.58
HDAC1 Q13547 6/20 0.58
HDAC7 Q8WUI4 6/20 0.58
HDAC2 Q92769 6/20 0.58
HDAC10 Q969S8 6/20 0.58
HDAC11 Q96DB2 6/20 0.58
HDAC8 Q9BY41 6/20 0.58
HDAC6 Q9UBN7 6/20 0.58
HDAC9 Q9UKV0 6/20 0.58
HDAC5 Q9UQL6 6/20 0.58
KDM4E B2RXH2 9/20 0.53
KLK7 P49862 1/20 0.53
HTT P42858 1/20 0.49
ATM Q13315 1/20 0.49
CA1 P00915 1/20 0.48
CA2 P00918 1/20 0.48
CA7 P43166 1/20 0.48
CA9 Q16790 1/20 0.48
ALDH1A1 P00352 6/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13005009 0.85 KDM4E (0.60) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL9963148 0.85 KDM4E (0.53) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL620146 0.85 KDM4E (0.63) KDM4EKLK7HTTATMCA1
SCHEMBL9444279 0.84 KDM4E (0.68) KDM4EKLK7HTTATMCA1
SCHEMBL1546824 0.78 HDAC3 (0.79) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL2594720 0.78 ALDH1A1 (0.59) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL13791467 0.77 CA1 (0.63) KDM4EKLK7CA1CA2CA7
SCHEMBL4519348 0.77 KDM4E (0.55) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL23957129 0.76 KDM4E (0.57) HDAC3HDAC4HDAC1HDAC7HDAC2
Hydrochloric Acid SCHEMBL8567618 0.76 KDM4E (0.54) HDAC3HDAC4HDAC1HDAC7HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8354403-B2 Pyrrolidine derived beta 3 adrenergic receptor agonists MERCK SHARP & DOHME CORP. (US) 2013-01-15 US disclosed
US-20120157432-A1 NOVEL PYRROLIDINE DERIVED BETA 3 ADRENERGIC RECEPTOR AGONISTS MERCK SHARP & DOHME, CORP. (US) 2012-06-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120157432-A1 NOVEL PYRROLIDINE DERIVED BETA 3 ADRENERGIC RECEPTOR AGONISTS ADRB3, ADRB1, ADRB2 HDAC3 1787/4885HDAC4 3491/4885HDAC1 3056/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.